Potential applications of intracellular antibodies (intrabodies) in stem cell therapeutics

Journal of Cellular and Molecular Medicine

Volumn 9, Issue 1, 2005, Pages 191-195

  Heng, Boon Chin ^a   Kemeny, David Michael ^b   Liu, Hua ^a   Cao, Tong ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY;

ANIMAL; DRUG EFFECT; GENE THERAPY; HUMAN; IMMUNOLOGY; INTRACELLULAR FLUID; METABOLISM; METHODOLOGY; REVIEW; STEM CELL;

ANIMALS; ANTIBODIES; GENE THERAPY; HUMANS; INTRACELLULAR FLUID; STEM CELLS;

EID: 17144395594     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2005.tb00348.x     Document Type: Review

References (36)

1. Marasco W.A., Intracellular antibodies (intrabodies) as research reagents and therapeutic molecules for gene therapy, Immunotechnology, 1: 1-19, 1995
2. Wheeler Y.Y., Chen S.Y., Sane D.C., Intrabody and intrakine strategies for molecular therapy, Mol Ther, 8: 355-366, 2003
3. Bird R.E., Hardman K.D., Jacobson J.W., Johnson S., Kaufman B.M., Lee S.M., Lee T., Pope S.H., Riordan G.S., Whitlow M., Single-chain antigen-binding proteins, Science, 242: 423-426, 1988
4. Tanaka T., Lobato M.N., Rabbitts T.H., Single domain intracellular antibodies: a minimal fragment for direct in vivo selection of antigen-specific intrabodies, J Mol Biol, 331: 1109-1120, 2003
5. Aires da Silva F., Santa-Marta M., Freitas-Vieira A., Mascarenhas P., Barahona I., Moniz-Pereira J., Gabuzda D., Goncalves J., Camelized rabbit-derived VH single-domain intrabodies against Vif strongly neutralize HIV-1 infectivity, J. Mol. Biol., 340: 525-542, 2004
6. Carlson J.R., A new means of inducibly inactivating a cellular protein, Mol. Cell Biol., 8: 2638-2646, 1988
7. Tanaka T., Rabbitts T.H., Intrabodies based on intracellular capture frameworks that bind the RAS protein with high affinity and impair oncogenic transformation, EMBO J., 22: 1025-1035, 2003
8. Cochet O., Kenigsberg M., Delumeau I., Virone-Oddos A., Multon M.C., Fridman W.H., Schweighoffer F., Teillaud J.L., Tocque B., Intracellular expression of an antibody fragment-neutralizing p21 ras promotes tumor regression, Cancer. Res., 58: 1170-1176, 1988
9. Deshane J., Siegal G.P., Alvarez R.D., Wang M.H., Feng M., Cabrera G., Liu T., Kay M., Curiel D.T., Targeted tumor killing via an intracellular antibody against erbB-2, J. Clin. Invest., 96: 2980-2989, 1995
10. Marasco W.A., Haseltine W.A., Chen S.Y., Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody, Proc. Natl. Acad. Sci. U. S. A., 90: 7889-7893, 1993
11. Maciejewski J.P., Weichold F.F., Young N.S., Cara A., Zella D., Reitz M.S., Gallo R.C., Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro, Nat. Med., 1: 667-673, 1995
12. Duan L., Zhu M., Bagasra O., Pomerantz R.J., Intracellular immunization against HIV-1 infection of human T lymphocytes: utility of anti-rev single-chain variable fragments, Hum. Gene. Ther., 6: 1561-1573, 1995
13. Bradley J.A., Bolton E.M., Pedersen R.A., Stem cell medicine encounters the immune system, Nat. Rev. Immuno., 2: 859-871, 2002
14. Tzukerman M., Rosenberg T., Ravel Y., Reiter I., Coleman R., Skorecki K., An experimental platform for studying growth and invasiveness of tumor cells within teratomas derived from human embryonic stem cells, Proc Natl. Acad. Sci. U. S. A., 100: 13507-13512, 2003
15. Heng B.C., Cao T., Haider H.K., Wang D.Z., Sim E.K., Ng S.C., An overview and synopsis of techniques for directing stem cell differentiation in vitro, Cell Tissue Res., 315: 291-303, 2004
16. Verfaillie C.M., Adult stem cells: assessing the case for pluripotency, Trends Cell Biol., 12: 502-508, 2002
17. Jackson A.L., Linsley P.S., Noise amidst the silence: off-target effects of siRNAs? Trends Genet., 20: 521-524, 2004
18. Sledz C.A., Williams B.R., RNA interference and double-stranded-RNA- activated pathways, Biochem. Soc. Trans., 32: 952-956, 2004
19. Snove O., Holen T., Many commonly used siRNAs risk off-target activity, Biochem. Biophys. Res. Commun., 319: 256-263, 2004
20. Persengiev S.P., Zhu X., Green M.R., Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs), RNA., 10: 12-18, 2004
21. Cattaneo A., Biocca S., The selection of intracellular antibodies, Trends Biotechnol., 17: 115-121, 1999
22. Zhou P., Bogacki R., McReynolds L., Howley P.M., Harnessing the ubiquitination machinery to target the degradation of specific cellular proteins, Mol. Cell., 6: 751-756, 2000
23. Tse E., Rabbitts T.H., Intracellular antibody-caspase-mediated cell killing: an approach for application in cancer therapy, Proc. Natl. Acad. Sci. U. S. A., 97: 12266-12271, 2000
24. Cowan C.A., Klimanskaya I., McMahon J., Atienza J., Witmyer J., Zucker J.P., Wang S., Morton C.C., McMahon A.P., Powers D., Melton D.A., Derivation of embryonic stem-cell lines from human blastocysts, N. Engl. J. Med., 350: 1353-1356, 2004
25. Hwang W.S., Ryu Y.J., Park J.H., Park E.S., Lee E.G, Koo J.M., Jeon H.Y., Lee B.C., Kang S.K., Kim S.J., Ahn C., Hwang J.H., Park K.Y., Cibelli J.B., Moon S.Y., Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst, Science, 303: 1669-1674, 2004
26. Mhashilkar A.M., Doebis C., Seifert M., Busch A., Zani C., Soo Hoo J., Nagy M., Ritter T., Volk H.D., Marasco W.A., Intrabody-mediated phenotypic knockout of major histocompatibility complex class I expression in human and monkey cell lines and in primary human keratinocytes, Gene Ther., 9: 307-319, 2002
27. Beyer F., Doebis C., Busch A., Ritter T., Mhashilkar A., Marasco W.M., Laube H., Volk H.D., Seifert M., Decline of surface MHC I by adenoviral gene transfer of anti-MHC I intrabodies in human endothelial cells-new perspectives for the generation of universal donor cells for tissue transplantation, J. Gene Med., 6: 616-23, 2004
28. Marasco W.A., Intrabodies: turning the humoral immune system outside in for intracellular immunization, Gene Ther., 4: 11-15, 1997
29. Schrem H., Klempnauer J., Borlak J., Liver-enriched transcription factors in liver function and development. I, The hepatocyte nuclear factor network and liver-specific gene expression, Pharmacol Rev., 54: 1129-1158, 2002
30. Shirasaki R., Pfaff S.L., Transcriptional codes and the control of neuronal identity, Annu. Rev. Neurosci., 25: 251-281, 2002
31. Sachinidis A., Fleischmann B.K., Kolossov E., Wartenberg M., Sauer H., Hescheler J., Cardiac specific differentiation of mouse embryonic stem cells, Cardiovasc. Res., 58: 2278-2291, 2003
32. Ng L.J., Wheatley S., Muscat G.E., Conway-Campbell J., Bowles J., Wright E., Bell D.M., Tam P.P., Cheah K.S., Koopman P., SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse, Dev Biol., 183: 108-121, 1997
33. Akiyama H., Chaboissier M.C., Martin J.F., Schedl A., de Crombrugghe B., The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6, Genes Dev., 16: 2813-2828, 2002
34. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J.M., Behringer R.R., de Crombrugghe B., The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation, Cell., 108: 117-129, 2002
35. Lian J.B., Javed A., Zaidi S.K., Lengner C., Montecino M., Van Wijnen A.J., Stein J.L., Stein G.S., Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors, Crit. Rev. Eukaryot. Gene Expr., 14: 1-42, 2003
36. Lobato M.N., Rabbitts T.H., Intracellular antibodies as specific reagents for functional ablation: future therapeutic molecules, Curr. Mol. Med., 4: 519-528, 2004